Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taltz and Enstilar in plaque psoriasis
NCT04372277Phase 4Recruiting
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of calcipotriol in plaque psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Started Apr 2020; status: recruiting.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04372277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372277.